Kopnin Bp
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 38
- Cancer-related Molecular Pathways 27
- Drug Transport and Resistance Mechanisms 5
-
- Epigenetics and DNA Methylation 7
- DNA Repair Mechanisms 6
- Ubiquitin and proteasome pathways 6
- Co-authors
- Peter M. Chumakov (31 shared papers)Pavel Kopnin (17 shared papers)Larissa S. Agapova (8 shared papers)Anna Sablina (6 shared papers)Н. В. Хромова (7 shared papers)Alexey V. Ivanov (7 shared papers)Andrei V. Gudkov (13 shared papers)Arnold J. Levine (2 shared papers)
- Journals
- Oncogene (7 papers)Journal of Biological Chemistry (2 papers)FEBS Letters (2 papers)Cytogenetic and Genome Research (2 papers)Chromosoma (2 papers)
- Partner nations
- RussiaUnited StatesUnited Kingdom
In The Last Decade
Kopnin Bp
77 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 100
- Oncology 619
- Cancer Research 311
- Cell Biology 263
- Biotechnology 133
- Molecular Biology 993
Countries citing papers authored by Kopnin Bp
This map shows the geographic impact of Kopnin Bp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kopnin Bp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kopnin Bp more than expected).
Fields of papers citing papers by Kopnin Bp
This network shows the impact of papers produced by Kopnin Bp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kopnin Bp. The network helps show where Kopnin Bp may publish in the future.
Co-authors
The 25 scholars most cited alongside Kopnin Bp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 116 | |
| 2 | 2002 | 83 | |
| 3 | 2008 | 76 | |
| 4 | 1998 | 69 | |
| 5 | Targets of oncogenes and tumor suppressors: key for understanding basic mechanisms of carcinogenesis. | 2000 | 68 |
| 6 | 2006 | 67 | |
| 7 | 1980 | 67 | |
| 8 | 2011 | 64 | |
| 9 | 1993 | 59 | |
| 10 | 1998 | 56 | |
| 11 | 1996 | 53 | |
| 12 | 2001 | 52 | |
| 13 | 2015 | 44 | |
| 14 | 2000 | 43 | |
| 15 | 2013 | 42 | |
| 16 | 2003 | 42 | |
| 17 | 1999 | 39 | |
| 18 | 1997 | 31 | |
| 19 | 1981 | 31 | |
| 20 | 1991 | 29 |
About Kopnin Bp
Kopnin Bp is a scholar working on Oncology, Molecular Biology, Genetics, Biotechnology and Cell Biology, having authored 79 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (27 papers), Cancer Research and Treatments (9 papers), Epigenetics and DNA Methylation (7 papers), Virus-based gene therapy research (6 papers), DNA Repair Mechanisms (6 papers), Ubiquitin and proteasome pathways (6 papers), Microtubule and mitosis dynamics (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). The work is most often cited by research in Oncology (619 citations), Cancer Research (311 citations), Cell Biology (263 citations), Biotechnology (133 citations) and Molecular Biology (993 citations). Kopnin Bp has collaborated with scholars based in Russia, United States and United Kingdom. Frequent co-authors include Peter M. Chumakov, Pavel Kopnin, Larissa S. Agapova, Anna Sablina, Н. В. Хромова, Alexey V. Ivanov, Andrei V. Gudkov, Arnold J. Levine, J. M. Vasiliev and Antonina Y. Alexandrova. Their work appears in journals such as Oncogene, Journal of Biological Chemistry, FEBS Letters, Cytogenetic and Genome Research and Chromosoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.